[F-18] N-METHYLSPIROPERIDOL - THE RADIOLIGAND OF CHOICE FOR PETT STUDIES OF THE DOPAMINE RECEPTOR IN HUMAN-BRAIN
[F-18] N-METHYLSPIROPERIDOL - THE RADIOLIGAND OF CHOICE FOR PETT STUDIES OF THE DOPAMINE RECEPTOR IN HUMAN-BRAIN
复制标题
DOI:
10.1016/0024-3205(85)90041-4
复制
发表时间:
1985-01-01
期刊:
影响因子:
6.1
通讯作者:
MCPHERSON, DW
中科院分区:
文献类型:
--
作者:
ARNETT, CD;FOWLER, JS;MCPHERSON, DW
N-Methylspiroperidol, the amide N-methyl analog of the neuroleptic spiroperidol, was radiolabeled with fluorine-18, and its distribution in the baboon brain was studied using positron emission transaxial tomography. Stereospecific binding was demonstrated in the striatum (but not in the cerebellum) by pretreatment with (-)- or (+)-butaclamol. The kinetic distribution was similar to that of [18F]spiroperidol, but the absolute striatal uptake (in percent of administered dose) was at least 2-fold higher. Analysis of baboon blood at 10 min after injection indicated that less than half of the radioactivity in the plasma was due to unchanged radioligand. Analysis of the metabolic stability of [18F]-N-methylspiroperidol in rat brain for 4 h indicated that, like [18F]spiroperidol, it is very stable to metabolic transformation in the rat CNS. Striatal uptake and retention in the rat was 5-fold higher for [18F]-N-methylspiroperidol than for [18F]spiroperidol. Apparently, [18F]-N-methylspiroperidol is an ideal choice for studies of the dopamine receptor in humans.